Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/943819/000094381918000016/rmd-20180930x10q.htm
SEC Filings
RMD Annual Reports
10-K Annual Report August 2022
10-K Annual Report August 2021
10-K Annual Report August 2020
10-K Annual Report August 2019
10-K Annual Report August 2018
10-K Annual Report August 2017
10-K Annual Report August 2016
10-K Annual Report August 2015
10-K Annual Report August 2014
10-K Annual Report August 2013
10-K Annual Report August 2022
10-K Annual Report August 2021
10-K Annual Report August 2020
10-K Annual Report August 2019
10-K Annual Report August 2018
10-K Annual Report August 2017
10-K Annual Report August 2016
10-K Annual Report August 2015
10-K Annual Report August 2014
10-K Annual Report August 2013
RMD Quarterly Reports
10-Q Quarterly Report January 2023
10-Q Quarterly Report October 2022
10-Q Quarterly Report April 2022
10-Q Quarterly Report January 2022
10-Q Quarterly Report October 2021
10-Q Quarterly Report April 2021
10-Q Quarterly Report January 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report January 2020
10-Q Quarterly Report January 2023
10-Q Quarterly Report October 2022
10-Q Quarterly Report April 2022
10-Q Quarterly Report January 2022
10-Q Quarterly Report October 2021
10-Q Quarterly Report April 2021
10-Q Quarterly Report January 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report January 2020
RMD Corporate News
Earnings Release
Event for Officers
Financial Exhibit
Other Events January 2023
Vote of Security Holders November 2022
Earnings Release
Financial Exhibit
Other Events October 2022
Earnings Release
Financial Exhibit
Other Events August 2022
Event for Officers
Financial Exhibit July 2022
Financial Exhibit
New Agreement
New Financial Obligation June 2022
Financial Exhibit
New Agreement
Regulated Disclosure June 2022
Event for Officers
Financial Exhibit May 2022
Earnings Release
Financial Exhibit
Other Events April 2022
Earnings Release
Financial Exhibit
Other Events January 2022
Earnings Release
Event for Officers
Financial Exhibit
Other Events
Event for Officers
Financial Exhibit
Other Events
January 2023
Vote of Security Holders
November 2022
Earnings Release
Financial Exhibit
Other Events
Financial Exhibit
Other Events
October 2022
Earnings Release
Financial Exhibit
Other Events
Financial Exhibit
Other Events
August 2022
Event for Officers
Financial Exhibit
Financial Exhibit
July 2022
Financial Exhibit
New Agreement
New Financial Obligation
New Agreement
New Financial Obligation
June 2022
Financial Exhibit
New Agreement
Regulated Disclosure
New Agreement
Regulated Disclosure
June 2022
Event for Officers
Financial Exhibit
Financial Exhibit
May 2022
Earnings Release
Financial Exhibit
Other Events
Financial Exhibit
Other Events
April 2022
Earnings Release
Financial Exhibit
Other Events
Financial Exhibit
Other Events
January 2022
Last10K.com | 10-Q Quarterly Report Fri Oct 26 2018
Exhibit 99.1
| For investors Amy Wakeham O: 858-836-5000 investorrelations@resmed.com |
For media Jayme Rubenstein O: 858-836-6798 news@resmed.com |
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019
~ Strong year-over-year growth in revenue, net income, and earnings per share ~
~ Growth balanced across the entire product portfolio ~
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. EDT today at http://investor.resmed.com
SAN DIEGO, October 25, 2018 – ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended September 30, 2018.
First Quarter 2019 Highlights
| • | Revenue increased 12% to $588.3 million; up 13% on a constant currency basis |
| • | Net income increased by 23%; non-GAAP net income up 23% |
| • | GAAP diluted earnings per share of $0.73; non-GAAP diluted earnings per share of $0.81 |
“Our first quarter 2019 results demonstrate continued strong performance across our business with 13 percent top-line revenue growth, driven by growth across our entire portfolio of offerings,” said Mick Farrell, ResMed’s chief executive officer. “We also delivered another quarter of improving operating leverage resulting in double-digit growth at the bottom line.”
Farrell continued, “During the quarter we expanded our product portfolio with new masks and made ongoing upgrades to our digital health solutions, separating ResMed from the competition. We provide customers with services and solutions to help improve patient outcomes, create efficiencies, and reduce overall healthcare system costs.”
The following information was filed by Resmed Inc (RMD) on Thursday, October 25, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Resmed Inc's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Resmed Inc.
Assess how Resmed Inc's management team is paid from their Annual Proxy
Resmed Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Income
Condensed Consolidated Statements Of Income
Business Combinations
Business Combinations (Narrative) (Details)
Debt
Debt (Narrative) (Details)
Debt (Schedule Of Debt) (Details)
Debt (Tables)
Derivative Instruments And Hedging Activities
Derivative Instruments And Hedging Activities (Narrative) (Details)
Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details)
Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details)
Derivative Instruments And Hedging Activities (Tables)
Earnings Per Share
Earnings Per Share (Narrative) (Details)
Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details)
Earnings Per Share (Tables)
Equity Investments
Equity Investments (Narrative) (Details)
Equity Investments (Schedule Of Reconciliation Of Changes In Equity Investments) (Details)
Equity Investments (Tables)
Fair Value Measurements
Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details)
Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details)
Fair Value Measurements (Tables)
Goodwill
Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details)
Goodwill (Tables)
Income Taxes
Income Taxes (Narrative) (Details)
Inventories
Inventories (Schedule Of Inventories) (Details)
Inventories (Tables)
Legal Actions And Contingencies
Legal Actions And Contingencies (Narrative) (Details)
Legal Actions And Contingencies (Summary Of Maximum Exposure On Outstanding Receivables Sold With Recourse And Provision) (Details)
Legal Actions And Contingencies (Summary Of Receivables Sold With Recourse) (Details)
Legal Actions And Contingencies (Tables)
Other Intangible Assets
Other Intangible Assets (Narrative) (Details)
Other Intangible Assets (Schedule Of Other Intangible Assets, Net) (Details)
Other Intangible Assets (Tables)
Product Warranties
Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details)
Product Warranties (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Components Of Property, Plant And Equipment) (Details)
Property, Plant And Equipment (Tables)
Stockholders' Equity
Stockholders' Equity (Narrative) (Details)
Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details)
Stockholders' Equity (Schedule Of Option Activity) (Details)
Stockholders' Equity (Tables)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Narrative) (Details)
Summary Of Significant Accounting Policies (Policy)
Summary Of Significant Accounting Policies (Schedule Of Reclassification Of Assets And Equity Upon Adoption Asu 2016-16) (Details)
Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details)
Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details)
Summary Of Significant Accounting Policies (Tables)
Material Contracts, Statements, Certifications & more
Resmed Inc provided additional information to their SEC Filing as exhibits
Ticker: RMD
CIK: 943819
Form Type: 10-Q Quarterly Report
Accession Number: 0000943819-18-000016
Submitted to the SEC: Thu Oct 25 2018 7:18:22 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Sunday, September 30, 2018
Industry: Surgical And Medical Instruments And Apparatus
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/rmd/0000943819-18-000016.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...